Literature DB >> 22201601

Regulation of glycolytic and mitochondrial metabolism by ras.

J Chesney1, S Telang.   

Abstract

High glucose uptake is a characteristic of most metastatic tumors and activation of Ras signaling in immortalized cells increases glycolytic flux into lactate, de novo nucleic acid synthesis and the tricarboxylic acid cycle, and increases NADH shuttling, oxygen consumption and uncoupling of ATP synthase from the proton gradient. Fructose-2,6- bisphosphate, C-Myc, HIF1α and AKT each have been found to be key regulators of glycolysis and to be controlled by Ras signaling, and there is abundant evidence for cross-talk between these regulators. The reprogramming of glycolytic and mitochondrial metabolism by Ras enables an integrated activation of energetic and anabolic pathways via the redox state of NADH that is required for the survival and growth of neoplastic cells in poorly vascularized tumors. Several small molecule antagonists specific for essential metabolic enzymes have been found to be selectively toxic to Ras-transformed cells as opposed to wild-type cells, indicating that this metabolic reprogramming and addiction may have utility for the development of anti-neoplastic agents.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 22201601     DOI: 10.2174/1389201011314030002

Source DB:  PubMed          Journal:  Curr Pharm Biotechnol        ISSN: 1389-2010            Impact factor:   2.837


  8 in total

1.  Type 2 Diabetes Dysregulates Glucose Metabolism in Cardiac Progenitor Cells.

Authors:  Joshua K Salabei; Pawel K Lorkiewicz; Parul Mehra; Andrew A Gibb; Petra Haberzettl; Kyung U Hong; Xiaoli Wei; Xiang Zhang; Qianhong Li; Marcin Wysoczynski; Roberto Bolli; Aruni Bhatnagar; Bradford G Hill
Journal:  J Biol Chem       Date:  2016-05-05       Impact factor: 5.157

2.  Autophagy suppresses progression of K-ras-induced lung tumors to oncocytomas and maintains lipid homeostasis.

Authors:  Jessie Yanxiang Guo; Gizem Karsli-Uzunbas; Robin Mathew; Seena C Aisner; Jurre J Kamphorst; Anne M Strohecker; Guanghua Chen; Sandy Price; Wenyun Lu; Xin Teng; Eric Snyder; Urmila Santanam; Robert S Dipaola; Tyler Jacks; Joshua D Rabinowitz; Eileen White
Journal:  Genes Dev       Date:  2013-07-01       Impact factor: 11.361

3.  c-Myc and cancer metabolism.

Authors:  Donald M Miller; Shelia D Thomas; Ashraful Islam; David Muench; Kara Sedoris
Journal:  Clin Cancer Res       Date:  2012-10-15       Impact factor: 12.531

4.  Reactive Oxygen Species Drive Proliferation in Acute Myeloid Leukemia via the Glycolytic Regulator PFKFB3.

Authors:  Andrew J Robinson; Goitseone L Hopkins; Namrata Rastogi; Marie Hodges; Michelle Doyle; Sara Davies; Paul S Hole; Nader Omidvar; Richard L Darley; Alex Tonks
Journal:  Cancer Res       Date:  2019-12-20       Impact factor: 12.701

5.  Lysophosphatidic Acid Up-Regulates Hexokinase II and Glycolysis to Promote Proliferation of Ovarian Cancer Cells.

Authors:  Abir Mukherjee; Yibao Ma; Fang Yuan; Yongling Gong; Zhenyu Fang; Esraa M Mohamed; Erika Berrios; Huanjie Shao; Xianjun Fang
Journal:  Neoplasia       Date:  2015-09       Impact factor: 5.715

Review 6.  To Eat and to Be Eaten: Mutual Metabolic Adaptations of Immune Cells and Intracellular Bacterial Pathogens upon Infection.

Authors:  Wolfgang Eisenreich; Thomas Rudel; Jürgen Heesemann; Werner Goebel
Journal:  Front Cell Infect Microbiol       Date:  2017-07-13       Impact factor: 5.293

7.  Cytochrome c oxidase is activated by the oncoprotein Ras and is required for A549 lung adenocarcinoma growth.

Authors:  Sucheta Telang; Kristin K Nelson; Deanna L Siow; Abdullah Yalcin; Joshua M Thornburg; Yoannis Imbert-Fernandez; Alden C Klarer; Hanan Farghaly; Brian F Clem; John W Eaton; Jason Chesney
Journal:  Mol Cancer       Date:  2012-08-23       Impact factor: 27.401

Review 8.  Pulmonary Pathogens Adapt to Immune Signaling Metabolites in the Airway.

Authors:  Sebastián A Riquelme; Tania Wong Fok Lung; Alice Prince
Journal:  Front Immunol       Date:  2020-03-13       Impact factor: 7.561

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.